Overview

A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold

Status:
RECRUITING
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
To further evaluate the efficacy and safety of Antiwei granule in the treatment of common cold (wind-cold syndrome)
Phase:
PHASE3
Details
Lead Sponsor:
Tasly Pharmaceutical Group Co., Ltd